TALPHERA, INC. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TALPHERA, INC. stock issued during period, shares, new issues for the quarter ending 2018-06-30 was 2.30M shares.
- TALPHERA, INC. stock issued during period, shares, new issues for the quarter ending 2017-12-31 was 1.20M shares.
- TALPHERA, INC. stock issued during period, shares, new issues for the quarter ending 2017-09-30 was 4.20M shares.
- TALPHERA, INC. stock issued during period, shares, new issues for fiscal 2017 was 5.40M shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2018-06-30 | 2.30M shares 10-Q · filed 2018-08-02 | |
| 2017-12-31 | 1.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | 5.40M shares 10-K · filed 2018-03-09 |
| 2017-09-30 | 4.20M shares 10-Q · filed 2017-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |